Psychotropic Medications Promote Time-Dependent Reduction of Suicidal Ideation in Mood Disorder: A Prospective Cohort Study
10.3346/jkms.2024.39.e226
- Author:
Jeong Hun YANG
1
;
C. Hyung Keun PARK
;
Sang Jin RHEE
;
Dae Hun KANG
;
Min Ji KIM
;
Hyun Jeong LEE
;
Sang Yeol LEE
;
Se-Hoon SHIM
;
Jung-Joon MOON
;
Seong-Jin CHO
;
Shin Gyeom KIM
;
Min-Hyuk KIM
;
Jinhee LEE
;
Won Sub KANG
;
Jieun YOO
;
Weon-Young LEE
;
Yong Min AHN
Author Information
1. Department of Psychiatry, Chungnam National University Sejong Hospital, Sejong, Korea
- Publication Type:Original Article
- From:Journal of Korean Medical Science
2024;39(31):e226-
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Despite a plethora of research on the topic, there is still no solid evidence that pharmacological treatment actually reduces the risk of suicide in patients with mental illness.In this study, we aimed to assess the effect of psychotropic medications on suicidal ideation in patients with major depressive disorder (MDD) and bipolar disorder (BPD) in two age groups: less than 25 years and 25 years and older.
Methods:We analyzed 312 patients with mood disorders with current suicidal thoughts or recent suicide attempts. We followed the participants from baseline for 6 months and assessed changes in suicidal ideation with Columbia-Suicide Severity Rating Scale (C-SSRS).The effect of psychotropic drug administration on suicidal ideation over time was analyzed using a linear mixed model.
Results:In patients aged 25 years and older with mood disorders, suicidal ideation was more severe when using psychotropic drugs than when not using them. However, suicidal ideation decreased rapidly over time. The time-dependent reduction in suicidal ideation was accelerated when using antidepressants and sedatives/hypnotics in adult MDD, and when using mood stabilizers in adult BPD. However, this effect was not observed in participants aged less than 25 years.
Conclusion:Adequate psychotropic medication may reduce suicidal ideation in patients with mood disorders aged 25 years and older. Additional research on psychotropic drugs is needed to effectively reduce the risk of suicide among children and adolescents with mood disorders.
